NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|133931212|ref|NP_503004|]
View 

NEPrilysin metallopeptidase family [Caenorhabditis elegans]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
96-711 6.97e-123

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 380.56  E-value: 6.97e-123
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  96 ADPCDNFYQSVCG---KQHE----HSLKSGLAKKHLILRNLIRETITN-RKVTPTSKSENEMRKFhgicskYQRANSSSD 167
Cdd:cd08662    1 VDPCDDFYQYACGnwlKNHPipadKSSWGSFSELQDRNEEQLREILEEaASSAADSSAEQKAKDF------YKSCMDEEA 74
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 168 IAQQALRDIFRDVQSIGSWPAGSRNWNESDFNLNEMLN------------------NLVKLGQRNFGLFQISFKYRDQll 229
Cdd:cd08662   75 IEKLGLKPLKPLLDKIGGLPSLDDLAAELLLALLRRLGvsllfglgvspdpknssrNILYLGQPGLGLPDRDYYLDEE-- 152
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 230 isAEEHRRNYSKLeptILNIFETNGLVPDRIQllKDLEGFASLEALLKNHY--------YLDNMDKMKPAVLDDLVPSVD 301
Cdd:cd08662  153 --NAEIREAYKKY---IAKLLELLGADEEEAE--KLAEDVLAFETELAKISlsseelrdPEKTYNPLTLAELQKLAPSID 225
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 302 FMGLVKAMISPGKEhlmpkieLKTSVLNQTLFNDenmNLEAIILDTPKRTLANYLIFNFIDSSLDHL--------VFETT 373
Cdd:cd08662  226 WKAYLKALGPPADD-------PDKVIVSQPEYLK---KLDKLLASTPLRTLKNYLIWRLLDSLAPYLskefrdarFFYGK 295
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 374 SQKGNT--------CEDKVITYLPRASLRVFIRNYVDKENRDLITQLAEKTRIALHTLVQNSTWLKAESKQLALDKINAM 445
Cdd:cd08662  296 ALSGQKepeprwkrCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAM 375
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 446 GKMIGYPDFFEPPGTLDGMFKNLNLdsSDTYYTALNKLERYFVEQKMDYFAEetPLDPDLrvFEM-----NAYYYIPGNQ 520
Cdd:cd08662  376 KVKIGYPDKWRDYSALDIYYDDLNV--SDSYFENVLRLLRFETKRQLAKLGK--PVDRTE--WSMspqtvNAYYNPSLNE 449
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 521 LNFLAPFFDDPMFDSTYPDYVNIAMSGNIIGHEMGHAFGPHAILRTVRGREV-WMKPEELAEYESRAQCLANQYSEYDDP 599
Cdd:cd08662  450 IVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRnWWTNEDRKEFEERAQCLVDQYSNYEVP 529
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 600 DFGRVfDGGKVIDELVADNIGREVSWKMFKSLDLTNATRIIGFEDYDIDQLYFRVGALTHC---TPHAMRDLkgSIESSH 676
Cdd:cd08662  530 PGLHV-NGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFAQVWCskyRPEALRQL--LLTDPH 606
                        650       660       670
                 ....*....|....*....|....*....|....*
gi 133931212 677 PRKAFRVNGVYANLPEFARAFNCPTGSPMNPRKKC 711
Cdd:cd08662  607 SPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
96-711 6.97e-123

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 380.56  E-value: 6.97e-123
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  96 ADPCDNFYQSVCG---KQHE----HSLKSGLAKKHLILRNLIRETITN-RKVTPTSKSENEMRKFhgicskYQRANSSSD 167
Cdd:cd08662    1 VDPCDDFYQYACGnwlKNHPipadKSSWGSFSELQDRNEEQLREILEEaASSAADSSAEQKAKDF------YKSCMDEEA 74
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 168 IAQQALRDIFRDVQSIGSWPAGSRNWNESDFNLNEMLN------------------NLVKLGQRNFGLFQISFKYRDQll 229
Cdd:cd08662   75 IEKLGLKPLKPLLDKIGGLPSLDDLAAELLLALLRRLGvsllfglgvspdpknssrNILYLGQPGLGLPDRDYYLDEE-- 152
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 230 isAEEHRRNYSKLeptILNIFETNGLVPDRIQllKDLEGFASLEALLKNHY--------YLDNMDKMKPAVLDDLVPSVD 301
Cdd:cd08662  153 --NAEIREAYKKY---IAKLLELLGADEEEAE--KLAEDVLAFETELAKISlsseelrdPEKTYNPLTLAELQKLAPSID 225
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 302 FMGLVKAMISPGKEhlmpkieLKTSVLNQTLFNDenmNLEAIILDTPKRTLANYLIFNFIDSSLDHL--------VFETT 373
Cdd:cd08662  226 WKAYLKALGPPADD-------PDKVIVSQPEYLK---KLDKLLASTPLRTLKNYLIWRLLDSLAPYLskefrdarFFYGK 295
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 374 SQKGNT--------CEDKVITYLPRASLRVFIRNYVDKENRDLITQLAEKTRIALHTLVQNSTWLKAESKQLALDKINAM 445
Cdd:cd08662  296 ALSGQKepeprwkrCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAM 375
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 446 GKMIGYPDFFEPPGTLDGMFKNLNLdsSDTYYTALNKLERYFVEQKMDYFAEetPLDPDLrvFEM-----NAYYYIPGNQ 520
Cdd:cd08662  376 KVKIGYPDKWRDYSALDIYYDDLNV--SDSYFENVLRLLRFETKRQLAKLGK--PVDRTE--WSMspqtvNAYYNPSLNE 449
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 521 LNFLAPFFDDPMFDSTYPDYVNIAMSGNIIGHEMGHAFGPHAILRTVRGREV-WMKPEELAEYESRAQCLANQYSEYDDP 599
Cdd:cd08662  450 IVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRnWWTNEDRKEFEERAQCLVDQYSNYEVP 529
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 600 DFGRVfDGGKVIDELVADNIGREVSWKMFKSLDLTNATRIIGFEDYDIDQLYFRVGALTHC---TPHAMRDLkgSIESSH 676
Cdd:cd08662  530 PGLHV-NGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFAQVWCskyRPEALRQL--LLTDPH 606
                        650       660       670
                 ....*....|....*....|....*....|....*
gi 133931212 677 PRKAFRVNGVYANLPEFARAFNCPTGSPMNPRKKC 711
Cdd:cd08662  607 SPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
511-712 1.66e-60

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 201.87  E-value: 1.66e-60
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  511 NAYYYIPGNQLNFLAPFFDDPMFDSTYPDYVNIAMSGNIIGHEMGHAFGPHAILRTVRGREV-WMKPEELAEYESRAQCL 589
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRsWWTDEDAEEFKDRAQCL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  590 ANQYSEYDDPDFGRVFDGGKVIDELVADNIGREVSWKMFKSLDLTNATRIIGFEDYDIDQLYFRVGALTHCT-PHAMRDL 668
Cdd:pfam01431  81 IEQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYKKLLSANETVLPGFENLTPDQLFFRGAAQIWCMkQSPAEVL 160
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....
gi 133931212  669 KGSIESSHPRKAFRVNGVYANLPEFARAFNCPTGSPMNPRKKCD 712
Cdd:pfam01431 161 RQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCR 204
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
287-705 3.34e-29

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 123.73  E-value: 3.34e-29
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 287 KMKPAVLDDLVPSVDFMGLVKAMISPGKEHLmpkielktSVLNQTLFNdenmNLEAIILDTPKRTLANYLIFNFIDSSLD 366
Cdd:COG3590  248 PMTVAELAKLAPGFDWDAYLKALGLPAVDEV--------IVGQPSFFK----ALDKLLASTPLEDWKAYLRWHLLDSAAP 315
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 367 HL--VFETTS----------QKGNTCEDKVITYLPRASL-----RVFIRNYVDKENRDLITQLAEKTRIALHTLVQNSTW 429
Cdd:COG3590  316 YLskAFVDANfdfygktlsgQKEQRPRWKRAVALVNGALgealgQLYVERYFPPEAKARMEELVANLRAAYRERIENLDW 395
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 430 LKAESKQLALDKINAMGKMIGYPDFFEppgtlDgmFKNLNLDSSDtYYTALNKLERYFVEQKMDYFAEetPLDPDlrVFE 509
Cdd:COG3590  396 MSPETKAKALEKLAAFTPKIGYPDKWR-----D--YSGLEIKRDD-LVGNVLRASAFEYQRELAKLGK--PVDRT--EWG 463
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 510 M-----NAYYYIPGNQLNFLA-----PFFDdPMFDstypDYVN---IamsGNIIGHEMGHAF---G----PHAILRTvrg 569
Cdd:COG3590  464 MtpqtvNAYYNPTMNEIVFPAailqpPFFD-PKAD----DAVNyggI---GAVIGHEITHGFddqGsqfdGDGNLRN--- 532
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 570 revWMKPEELAEYESRAQCLANQYSEYddpdfgRVFDGGKV-----IDELVADNIGREVSWKMFK-SLDLTNATRIIGFE 643
Cdd:COG3590  533 ---WWTPEDRAAFEARTKKLVAQYDAY------EPLPGLHVngkltLGENIADLGGLSIAYDAYKlSLKGKEAPVIDGFT 603
                        410       420       430       440       450       460
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 133931212 644 DydiDQLYF----RVGAlTHCTPHAMRDLkgsIES-SHPRKAFRVNGVYANLPEFARAFNCPTGSPM 705
Cdd:COG3590  604 G---DQRFFlgwaQVWR-SKARDEALRQR---LATdPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKM 663
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
96-711 6.97e-123

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 380.56  E-value: 6.97e-123
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  96 ADPCDNFYQSVCG---KQHE----HSLKSGLAKKHLILRNLIRETITN-RKVTPTSKSENEMRKFhgicskYQRANSSSD 167
Cdd:cd08662    1 VDPCDDFYQYACGnwlKNHPipadKSSWGSFSELQDRNEEQLREILEEaASSAADSSAEQKAKDF------YKSCMDEEA 74
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 168 IAQQALRDIFRDVQSIGSWPAGSRNWNESDFNLNEMLN------------------NLVKLGQRNFGLFQISFKYRDQll 229
Cdd:cd08662   75 IEKLGLKPLKPLLDKIGGLPSLDDLAAELLLALLRRLGvsllfglgvspdpknssrNILYLGQPGLGLPDRDYYLDEE-- 152
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 230 isAEEHRRNYSKLeptILNIFETNGLVPDRIQllKDLEGFASLEALLKNHY--------YLDNMDKMKPAVLDDLVPSVD 301
Cdd:cd08662  153 --NAEIREAYKKY---IAKLLELLGADEEEAE--KLAEDVLAFETELAKISlsseelrdPEKTYNPLTLAELQKLAPSID 225
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 302 FMGLVKAMISPGKEhlmpkieLKTSVLNQTLFNDenmNLEAIILDTPKRTLANYLIFNFIDSSLDHL--------VFETT 373
Cdd:cd08662  226 WKAYLKALGPPADD-------PDKVIVSQPEYLK---KLDKLLASTPLRTLKNYLIWRLLDSLAPYLskefrdarFFYGK 295
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 374 SQKGNT--------CEDKVITYLPRASLRVFIRNYVDKENRDLITQLAEKTRIALHTLVQNSTWLKAESKQLALDKINAM 445
Cdd:cd08662  296 ALSGQKepeprwkrCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAM 375
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 446 GKMIGYPDFFEPPGTLDGMFKNLNLdsSDTYYTALNKLERYFVEQKMDYFAEetPLDPDLrvFEM-----NAYYYIPGNQ 520
Cdd:cd08662  376 KVKIGYPDKWRDYSALDIYYDDLNV--SDSYFENVLRLLRFETKRQLAKLGK--PVDRTE--WSMspqtvNAYYNPSLNE 449
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 521 LNFLAPFFDDPMFDSTYPDYVNIAMSGNIIGHEMGHAFGPHAILRTVRGREV-WMKPEELAEYESRAQCLANQYSEYDDP 599
Cdd:cd08662  450 IVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRnWWTNEDRKEFEERAQCLVDQYSNYEVP 529
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 600 DFGRVfDGGKVIDELVADNIGREVSWKMFKSLDLTNATRIIGFEDYDIDQLYFRVGALTHC---TPHAMRDLkgSIESSH 676
Cdd:cd08662  530 PGLHV-NGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSFAQVWCskyRPEALRQL--LLTDPH 606
                        650       660       670
                 ....*....|....*....|....*....|....*
gi 133931212 677 PRKAFRVNGVYANLPEFARAFNCPTGSPMNPRKKC 711
Cdd:cd08662  607 SPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
511-712 1.66e-60

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 201.87  E-value: 1.66e-60
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  511 NAYYYIPGNQLNFLAPFFDDPMFDSTYPDYVNIAMSGNIIGHEMGHAFGPHAILRTVRGREV-WMKPEELAEYESRAQCL 589
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRsWWTDEDAEEFKDRAQCL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  590 ANQYSEYDDPDFGRVFDGGKVIDELVADNIGREVSWKMFKSLDLTNATRIIGFEDYDIDQLYFRVGALTHCT-PHAMRDL 668
Cdd:pfam01431  81 IEQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYKKLLSANETVLPGFENLTPDQLFFRGAAQIWCMkQSPAEVL 160
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....
gi 133931212  669 KGSIESSHPRKAFRVNGVYANLPEFARAFNCPTGSPMNPRKKCD 712
Cdd:pfam01431 161 RQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCR 204
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
287-705 3.34e-29

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 123.73  E-value: 3.34e-29
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 287 KMKPAVLDDLVPSVDFMGLVKAMISPGKEHLmpkielktSVLNQTLFNdenmNLEAIILDTPKRTLANYLIFNFIDSSLD 366
Cdd:COG3590  248 PMTVAELAKLAPGFDWDAYLKALGLPAVDEV--------IVGQPSFFK----ALDKLLASTPLEDWKAYLRWHLLDSAAP 315
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 367 HL--VFETTS----------QKGNTCEDKVITYLPRASL-----RVFIRNYVDKENRDLITQLAEKTRIALHTLVQNSTW 429
Cdd:COG3590  316 YLskAFVDANfdfygktlsgQKEQRPRWKRAVALVNGALgealgQLYVERYFPPEAKARMEELVANLRAAYRERIENLDW 395
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 430 LKAESKQLALDKINAMGKMIGYPDFFEppgtlDgmFKNLNLDSSDtYYTALNKLERYFVEQKMDYFAEetPLDPDlrVFE 509
Cdd:COG3590  396 MSPETKAKALEKLAAFTPKIGYPDKWR-----D--YSGLEIKRDD-LVGNVLRASAFEYQRELAKLGK--PVDRT--EWG 463
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 510 M-----NAYYYIPGNQLNFLA-----PFFDdPMFDstypDYVN---IamsGNIIGHEMGHAF---G----PHAILRTvrg 569
Cdd:COG3590  464 MtpqtvNAYYNPTMNEIVFPAailqpPFFD-PKAD----DAVNyggI---GAVIGHEITHGFddqGsqfdGDGNLRN--- 532
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212 570 revWMKPEELAEYESRAQCLANQYSEYddpdfgRVFDGGKV-----IDELVADNIGREVSWKMFK-SLDLTNATRIIGFE 643
Cdd:COG3590  533 ---WWTPEDRAAFEARTKKLVAQYDAY------EPLPGLHVngkltLGENIADLGGLSIAYDAYKlSLKGKEAPVIDGFT 603
                        410       420       430       440       450       460
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 133931212 644 DydiDQLYF----RVGAlTHCTPHAMRDLkgsIES-SHPRKAFRVNGVYANLPEFARAFNCPTGSPM 705
Cdd:COG3590  604 G---DQRFFlgwaQVWR-SKARDEALRQR---LATdPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKM 663
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
98-452 6.58e-28

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 116.24  E-value: 6.58e-28
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212   98 PCDNFYQSVCGK-QHEHSLKSG---------LAKK-HLILRNLIRETITNrkvTPTSKSENEMRKFhgicskYQRANSSS 166
Cdd:pfam05649   1 PCDDFYQYACGGwLKNHPIPADksswgtfdeLRERnEKQLREILEEAAAS---ESDPGAVEKAKDL------YKSCMDTD 71
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  167 DIAQQALRDIFRDVQSIGSWPAgsrnwNESDFNLNEML------------------------NNLVKLGQRNFGLFQISF 222
Cdd:pfam05649  72 AIEKLGLKPLKPLLDEIGGPLA-----NKDKFDLLETLaklrrygvdslfgfgvgpddknssRNILYLDQPGLGLPDRDY 146
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  223 kYRDQLLISAEEHRRNYSKLEPTILNIFETNGLVPDRIQLLKDLEgfaslEALLKNHY-------YLDNMDKMKPAVLDD 295
Cdd:pfam05649 147 -YLKDRDEKSAEIREAYKAYIAKLLTLLGASEEAAALAEEVLAFE-----TKLAKASLsreerrdPEKTYNPMTLAELQK 220
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  296 LVPSVDFMGLVKAMISPGKEhlmpkiELKTSVLNQTLFNdenmNLEAIILDTPKRTLANYLIFNFIDSSLDHL------- 368
Cdd:pfam05649 221 LAPGIDWKAYLNAAGLPDVP------SDEVIVSQPEYLK----ALSKLLAETPLRTLKNYLIWRLVRSLAPYLsdefrda 290
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 133931212  369 VFETTSQKGNT--------CEDKVITYLPRASLRVFIRNYVDKENRDLITQLAEKTRIALHTLVQNSTWLKAESKQLALD 440
Cdd:pfam05649 291 NFEFYGTLSGTkqrprwkrCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDWMDEETKKKALE 370
                         410
                  ....*....|..
gi 133931212  441 KINAMGKMIGYP 452
Cdd:pfam05649 371 KLDAMTVKIGYP 382
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH